Skip to content

Prevention of delirium in acute stroke

Prevention of delirium in acute stroke - PODIAS

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35482
Enrollment
300
Registered
2010-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

confusion

Interventions

Haloperidol 1 mg 3 times daily for three days.

Sponsors

Kennemer Gasthuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with (suspected) stroke - no delirium on admission (DRS48 hours - Score on deliersticker * 5 - Time between admission and estimation of risk score and DRS/CAM

Exclusion criteria

Exclusion criteria: - Score deliersticker 12; CAM * 2+1; CAM-ICU * 2 + 1) - not able to perform delirum screening (DRS, CAM, CAM-ICU) on admission - expected duriong of hospitalisation

Design outcomes

Primary

MeasureTime frame
occurence of delirium

Secondary

MeasureTime frame
Duration of delirium Severity of delirium Duration of admission Score on Modified Rankin Scale at discharge Discharge place (home, rehabilitation center, nursing home) Mortality and morbidity at discharge, and six weeks and one year after discharge

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)